CoralOghenerukevweOmeneMDPhD

Breast Cancer, Hematologic Oncology

Program Director, Breast Cancer Disparities Research; Associate Professor of Medicine; Rutgers Cancer Institute; Division of Medical Oncology; Rutgers, The State University of New Jersey

Join to view full profile

Dr. Omene is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Omene's full profile

Already have an account?

Office
195 Little Albany St.
New Brunswick, NJ 08903
Phone+1 732-235-9692

Fax+1 732-235-7943

Education & Training

NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2006
Columbia University Vagelos College of Physicians and SurgeonsClass of 2003

Certifications & Licensure

NJ State Medical License 2017 - 2025
NY State Medical License 2005 - 2017
American Board of Internal Medicine Medical Oncology

Clinical Trials

Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases Start of enrollment: 2011 Aug 19
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

2 citations
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda
Nature Medicine. 2024-12-01
8 citations
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-12-01
2 citations
Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community-engaged development and pilot testing of...
Jinghua An, Jeanne M Ferrante, Myneka Macenat, Shridar Ganesan, Shawna V Hudson
Cancer. 2024-10-15

Press Mentions

OP-ED: Breast Cancer Clinical Trials Are Missing Black WomenJanuary 23rd, 2025
Thousands of Women with Breast Cancer May Soon Be Told They Don't Need ANY Treatment… as Top Surgeons Reveal an Extraordinary Breakthrough That Could Change EverythingDecember 22nd, 2024